We are developing the world’s most advanced platform to discover novel microbiome-based therapeutics for dermatologic indications. Our platform is enabled by terabytes of DNA sequencing data derived from human skin samples across healthy individuals and patients with targeted skin diseases and a cutting-edge technology platform to successfully identify the functions added and lost to the microbiome by organisms; we seek to extract unique insights and understand the implications for skin health.